Lifecore Biomedical, Inc. Common Stock LFCR
$6.52
+55.24%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (1 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $6.50
- Implied Upside
- -0.3%
- Price Target Range
- $6.50 – $6.50
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-28 | William BlairMax Smock |
Downgrades | Outperform → Market perform | — |
| 2026-06-16 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $6 → $7 |
| 2026-04-29 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $6 → $6 |
| 2026-03-27 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $6 |
| 2026-03-24 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $6 |
| 2026-03-17 | Barrington ResearchMichael Petusky |
Upgrades | Market perform → Outperform | $6 |
| 2025-09-04 | KeybancPaul Knight |
Initiates coverage on | Sector weight | — |
| 2025-05-21 | William BlairMax Smock |
Initiates coverage on | Outperform | — |
| 2025-01-03 | Stephens & Co.Jacob Johnson |
Reiterates | Equal-weight | $6 |
| 2024-11-22 | Craig-HallumMatthew Hewitt |
Maintains | Buy | $8 → $10 |
| 2024-09-05 | Craig-HallumMatthew Hewitt |
Initiates coverage on | Buy | $8 |
| 2024-08-28 | Barrington ResearchMichael Petusky |
Downgrades | Outperform → Market perform | — |
| 2023-09-01 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $11 → $10 |
| 2023-09-01 | Stephens & Co.Jacob Johnson |
Maintains | Equal-weight | $8 → $9 |
| 2023-06-02 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $10 → $11 |
| 2023-05-24 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $8 → $10 |
| 2023-03-21 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $10 → $8 |
| 2023-03-20 | Barrington ResearchMichael Petusky |
Maintains | Outperform | $10 → $8 |
| 2023-03-20 | Stephens & Co.Jacob Johnson |
Downgrades | Overweight → Equal-weight | $11 → $2 |
| 2023-03-17 | Stephens & Co.Jacob Johnson |
Reiterates | Overweight | $11 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $6.52
- Market Cap
- $158.98 million
- 52-Week Range
- $3.63 – $8.98
- Average Volume
- 268K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.